NCS1
geneOn this page
Also known as NCS-1
Summary
NCS1 (neuronal calcium sensor 1, HGNC:3953) is a protein-coding gene on chromosome 9q34.11, encoding Neuronal calcium sensor 1 (P62166). Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner.
This gene is a member of the neuronal calcium sensor gene family, which encode calcium-binding proteins expressed predominantly in neurons. The protein encoded by this gene regulates G protein-coupled receptor phosphorylation in a calcium-dependent manner and can substitute for calmodulin. The protein is associated with secretory granules and modulates synaptic transmission and synaptic plasticity. Multiple transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 23413 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 23 total
- Druggable target: yes
- MANE Select transcript:
NM_014286
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3953 |
| Approved symbol | NCS1 |
| Name | neuronal calcium sensor 1 |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NCS-1 |
| Ensembl gene | ENSG00000107130 |
| Ensembl biotype | protein_coding |
| OMIM | 603315 |
| Entrez | 23413 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000372398, ENST00000493042, ENST00000630865, ENST00000937011, ENST00000937012, ENST00000946320, ENST00000946321, ENST00000946322
RefSeq mRNA: 2 — MANE Select: NM_014286
NM_001128826, NM_014286
CCDS: CCDS6932, CCDS78448
Canonical transcript exons
ENST00000372398 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000927338 | 130217832 | 130217970 |
| ENSE00000927339 | 130219725 | 130219803 |
| ENSE00000927340 | 130222650 | 130222738 |
| ENSE00000927341 | 130223082 | 130223159 |
| ENSE00001052772 | 130226389 | 130226504 |
| ENSE00001457687 | 130232990 | 130237303 |
| ENSE00001457688 | 130172404 | 130172727 |
| ENSE00003506681 | 130200958 | 130200982 |
Expression profiles
Bgee: expression breadth ubiquitous, 226 present calls, max score 98.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.1790 / max 506.9513, expressed in 1704 samples.
FANTOM5 promoters (12 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98992 | 31.6266 | 1700 |
| 98993 | 3.7004 | 1311 |
| 98995 | 1.0262 | 639 |
| 98994 | 0.6209 | 336 |
| 98996 | 0.6159 | 387 |
| 98997 | 0.5240 | 293 |
| 99005 | 0.3693 | 150 |
| 99003 | 0.2801 | 122 |
| 99006 | 0.1702 | 70 |
| 98998 | 0.1234 | 57 |
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right frontal lobe | UBERON:0002810 | 98.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 98.38 | gold quality |
| amygdala | UBERON:0001876 | 98.28 | gold quality |
| nucleus accumbens | UBERON:0001882 | 98.28 | gold quality |
| cingulate cortex | UBERON:0003027 | 98.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.79 | gold quality |
| postcentral gyrus | UBERON:0002581 | 97.69 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.13 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.13 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.12 | gold quality |
| Ammon’s horn | UBERON:0001954 | 97.05 | gold quality |
| parietal lobe | UBERON:0001872 | 97.02 | gold quality |
| frontal cortex | UBERON:0001870 | 96.81 | gold quality |
| neocortex | UBERON:0001950 | 96.72 | gold quality |
| temporal lobe | UBERON:0001871 | 96.54 | gold quality |
| cortical plate | UBERON:0005343 | 96.44 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 96.36 | gold quality |
| cerebral cortex | UBERON:0000956 | 96.20 | gold quality |
| telencephalon | UBERON:0001893 | 96.20 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.91 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 95.54 | gold quality |
| putamen | UBERON:0001874 | 95.53 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.50 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 95.48 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.28 | gold quality |
| popliteal artery | UBERON:0002250 | 95.26 | gold quality |
| tibial artery | UBERON:0007610 | 95.25 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.09 | gold quality |
| lower esophagus | UBERON:0013473 | 95.05 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 962.15 |
| E-GEOD-109979 | no | 66.76 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
159 targeting NCS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-4650-5P | 99.98 | 64.69 | 999 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
Literature-anchored findings (GeneRIF, showing 35)
- up-regulated in the prefrontal cortex of schizophrenic and bipolar patients (PMID:12496348)
- Analysis with chimeric proteins between KChIP2 and NCS-1 reveals that the three regions of KChIP2 are necessary and sufficient for its effective binding to Kv4.3 protein (PMID:12928444)
- may serve as regulator of certain isoforms of phosphatidylinositol 4-kinase (PMID:14512421)
- key role for residues within the motif EELTRK in NCS-1 in keeping the myristoyl group exposed and allowing the protein to be constitutively membrane-associated. (PMID:14726528)
- NCS-1 is shown to be mainly associated with azurophilic granules in human neutrophils and promyelocitic cells and, therefore could play an instrumental role in the calcium-dependent secretion of azurophilic granules (PMID:14760944)
- These results demonstrate a novel role for NCS-1 and PI4Kbeta in regulating ERK1/2 signaling and inflammatory reactions in mast cells. (PMID:16837555)
- occurrence of an unusual TG 3’ splice site in intron 2 (PMID:17672918)
- NCS-1 expression was diminished in CD4+T lymphocytes, CD19+ B lymphocytes and CD14+ monocytes of bipolar disorder patients and also decreased in CD4+ T lymphocytes and CD56+ natural killer cells of schizophrenia patients (PMID:19091302)
- Impairment of the normal cycling of NCS-1 by the R102Q mutation could have subtle effects on neuronal signalling and physiology in the developing and adult brain. (PMID:20479890)
- NCS-1 is a novel regulator of cardiac calcium signaling, specifically in immature and hypertrophic hearts. (PMID:21737792)
- [review] Receptor interaction properties in schizophrenia are dependent upon NCS-1, a protein found to regulate the phosphorylation, trafficking, and signaling profile of the D2 dopamine receptor (D2R) in neurons. (PMID:21777187)
- it is possible to protect cells from paclitaxel-induced degradation of NCS-1 by inhibiting calpain activity (PMID:21808066)
- analysis of the interaction between the D2 dopamine receptor and neuronal calcium sensor-1 (PMID:21875085)
- the C-terminal tail is important for regulating the conformational stability of NCS1 in Ca(2+)-activated state (PMID:22227393)
- data suggest that genetic variants in the NCS-1 gene contribute to susceptibility of Cocaine Abuse in individuals of African descent. (PMID:22999924)
- NCS1 has evolved a remarkable complex interdomain cooperativity and a fundamentally different folding mechanism compared to structurally related proteins. (PMID:24012477)
- The functional link in substantia nigra dopamine neurons between Cav1.3- L-type-Ca2+ channels and D2-autoreceptor activity is an adaptive signalling network controlled by NCS-1. (PMID:24934288)
- single-molecule optical tweezers were used to monitor misfolding reactions of the human neuronal calcium sensor-1. (PMID:25157171)
- results reveal the important role of salt bridges on the structural properties of NCS-1 protein and that R102Q mutation disables the dynamic relocation of C-terminus, which may block the binding of NCS-1 protein to its receptors (PMID:25343687)
- A strong liason was characterized between myristoylation and cryptic EF-1 in NCS-1. (PMID:25565019)
- Study determined the salient features of the folding free-energy landscapes of the Mg2+-bound and apo states of NCS-1 (PMID:26153708)
- structural and dynamical response of NCS-1 protein to elevated temperature may be one of its intrinsic functional properties (PMID:27007011)
- Lithium normalizes gamma band oscillations mediated by P/Q-type calcium channels modulated by NCS-1. (PMID:27033453)
- Results show that although NCS-1 Var2mRNA can be detected, protein expression was not detectable. When overexpressed in cell lines NCS-1 Var2 appears to be folded properly, yet it has a lower calcium affinity. Because most NCS-1 binding to its protein partners requires calcium binding, it is unlikely that NCS-1 Var2 would play a major regulatory role in cells. (PMID:27575489)
- NCS-1, a calcium-binding protein, is associated with clinicopathologic features of aggressiveness in breast cancer cells and worse outcome in two breast cancer patient cohorts (PMID:28275088)
- High NCS1 expression is associated with Hepatocellular Carcinoma. (PMID:29789326)
- NCS1 regulates endoplasmic reticulum-mitochondria cross-talk, which is impaired in Wolfram syndrome (PMID:30352948)
- NCS-1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin. (PMID:31647602)
- NCS-1 levels were reduced in a human iPSC-model of familial Parkinson’s. (PMID:31704946)
- Membrane Binding of Neuronal Calcium Sensor-1: Highly Specific Interaction with Phosphatidylinositol-3-Phosphate. (PMID:31973069)
- Neuronal Calcium Sensor 1 is up-regulated in response to stress to promote cell survival and motility in cancer cells. (PMID:32239615)
- Disorder in a two-domain neuronal Ca(2+)-binding protein regulates domain stability and dynamics using ligand mimicry. (PMID:32936312)
- Disulfide Dimerization of Neuronal Calcium Sensor-1: Implications for Zinc and Redox Signaling. (PMID:34830487)
- [Neuronal Calcium Sensor-1: A Zinc/Redox-Dependent Protein of Nervous System Signaling Pathways]. (PMID:38062964)
- NCS-1 protein regulates TRPA1 channel through the PI3K pathway in breast cancer and neuronal cells. (PMID:38564162)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ncs1b | ENSDARG00000054186 |
| danio_rerio | ncs1a | ENSDARG00000055229 |
| mus_musculus | Ncs1 | ENSMUSG00000062661 |
| drosophila_melanogaster | CG7646 | FBGN0036926 |
| drosophila_melanogaster | CG5890 | FBGN0039380 |
| caenorhabditis_elegans | ncs-2 | WBGENE00003564 |
| caenorhabditis_elegans | WBGENE00015867 |
Paralogs (14): CLXN (ENSG00000034239), GUCA1A (ENSG00000048545), NCALD (ENSG00000104490), RCVRN (ENSG00000109047), GUCA1B (ENSG00000112599), KCNIP3 (ENSG00000115041), HPCAL1 (ENSG00000115756), HPCAL4 (ENSG00000116983), KCNIP2 (ENSG00000120049), HPCA (ENSG00000121905), GUCA1C (ENSG00000138472), VSNL1 (ENSG00000163032), KCNIP1 (ENSG00000182132), KCNIP4 (ENSG00000185774)
Protein
Protein identifiers
Neuronal calcium sensor 1 — P62166 (reviewed: P62166)
Alternative names: Frequenin homolog, Frequenin-like protein, Frequenin-like ubiquitous protein
All UniProt accessions (1): P62166
UniProt curated annotations — full annotation on UniProt →
Function. Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner. Directly regulates GRK1 (RHOK), but not GRK2 to GRK5. Can substitute for calmodulin. Stimulates PI4KB kinase activity. Involved in long-term synaptic plasticity through its interaction with PICK1. May also play a role in neuron differentiation through inhibition of the activity of N-type voltage-gated calcium channel.
Subunit / interactions. Monomer. Interacts with KCND2. Interacts in a calcium-independent manner with PI4KB. This binding competes with CALN2/CABP7 binding to PI4KB. Interacts in a calcium-dependent manner with PICK1 (via AH domain). Interacts with ARF1, ARF3, ARF5 and ARF6. Interacts with IL1RAPL1. Interacts with RIC8A; interaction is favored in the absence of Ca(2+) and myristoylation of NCS1 is not required.
Subcellular location. Golgi apparatus. Postsynaptic density. Cytoplasm. Perinuclear region. Cell membrane. Membrane.
Miscellaneous. Binds 3 calcium ions via the second, third and fourth EF-hand.
Similarity. Belongs to the recoverin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P62166-1 | 1 | yes |
| P62166-2 | 2 |
RefSeq proteins (2): NP_001122298, NP_055101* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR028846 | Recoverin | Family |
Pfam: PF00036, PF13499
UniProt features (52 total): binding site 16, helix 14, strand 7, domain 4, mutagenesis site 4, sequence conflict 2, initiator methionine 1, chain 1, lipid moiety-binding region 1, splice variant 1, region of interest 1
Structure
Experimental structures (PDB)
14 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9GUA | X-RAY DIFFRACTION | 1.65 |
| 9GU8 | X-RAY DIFFRACTION | 1.67 |
| 8AHY | X-RAY DIFFRACTION | 1.7 |
| 4GUK | X-RAY DIFFRACTION | 1.75 |
| 6QI4 | X-RAY DIFFRACTION | 1.78 |
| 8ALM | X-RAY DIFFRACTION | 1.85 |
| 8ALH | X-RAY DIFFRACTION | 1.86 |
| 1G8I | X-RAY DIFFRACTION | 1.9 |
| 9T0H | X-RAY DIFFRACTION | 1.91 |
| 9GU6 | X-RAY DIFFRACTION | 1.93 |
| 9GUZ | X-RAY DIFFRACTION | 2.28 |
| 9GTO | X-RAY DIFFRACTION | 2.3 |
| 5O9S | X-RAY DIFFRACTION | 2.7 |
| 2LCP | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P62166-F1 | 88.26 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (16): 79; 81; 84; 109; 111; 113; 115; 120; 157; 159; 161; 163 …
Post-translational modifications (1): 2
Mutagenesis-validated functional residues (4):
| Position | Phenotype |
|---|---|
| 2 | no effect on interaction with ric8a. |
| 81 | reduces calcium binding; when associated with a-117 or a-165. abolishes calcium binding; when associated with a-117 and |
| 117 | reduces calcium binding; when associated with t-81. abolishes calcium binding; when associated with t-81 and a-165. |
| 165 | reduces calcium binding; when associated with a-117. abolishes calcium binding; when associated with t-81 and a-117. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 181 (showing top):
TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GOBP_NEUROGENESIS, GOBP_MONOATOMIC_CATION_TRANSPORT, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, BACH2_01, TGANTCA_AP1_C, TTGGAGA_MIR5155P_MIR519E, GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GCM_MAPK10, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT
GO Biological Process (3): regulation of signal transduction (GO:0009966), regulation of neuron projection development (GO:0010975), calcium ion transmembrane transport (GO:0070588)
GO Molecular Function (5): voltage-gated calcium channel activity (GO:0005245), calcium ion binding (GO:0005509), calcium sensitive guanylate cyclase activator activity (GO:0008048), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (10): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cytosol (GO:0005829), plasma membrane (GO:0005886), postsynaptic density (GO:0014069), axon (GO:0030424), dendrite (GO:0030425), perinuclear region of cytoplasm (GO:0048471), membrane (GO:0016020), synapse (GO:0045202)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cytoplasm | 3 |
| neuron projection | 2 |
| signal transduction | 1 |
| regulation of cell communication | 1 |
| regulation of signaling | 1 |
| regulation of response to stimulus | 1 |
| neuron projection development | 1 |
| regulation of plasma membrane bounded cell projection organization | 1 |
| calcium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| calcium channel activity | 1 |
| voltage-gated monoatomic cation channel activity | 1 |
| metal ion binding | 1 |
| guanylate cyclase activator activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| asymmetric synapse | 1 |
| postsynaptic specialization | 1 |
| dendritic tree | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
127 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DTX2 | NCS1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| NCS1 | DTX2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| MGLL | HPCAL1 | psi-mi:“MI:0914”(association) | 0.640 |
| HSD17B3 | NCS1 | psi-mi:“MI:0915”(physical association) | 0.620 |
| NCS1 | CEP89 | psi-mi:“MI:0915”(physical association) | 0.600 |
| NBL1 | NCS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | NBL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | SFTPA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | LY6G6D | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | CREM | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| NCS1 | PRDM4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | CTAG1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | SIGLEC9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | SPRED2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCS1 | ZC3H10 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (115): NCS1 (Two-hybrid), DTX2 (Two-hybrid), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), DTX2 (Two-hybrid), NCS1 (Proximity Label-MS), NCS1 (Two-hybrid), NCS1 (Affinity Capture-MS), IL1RAPL1 (Two-hybrid), BSPRY (Affinity Capture-MS), ABHD6 (Affinity Capture-MS), NMT2 (Affinity Capture-MS)
ESM2 similar proteins: A9JTH1, B3DLU1, B3VSB7, B5FZ84, P29104, P29105, P35332, P36608, P37235, P37236, P42324, P42325, P61601, P61602, P62166, P62167, P62168, P62748, P62749, P62758, P62759, P62760, P62761, P62762, P62763, P62764, P84074, P84075, P84076, Q06AT0, Q06AT1, Q09711, Q16982, Q28IM6, Q4PL64, Q4R4N4, Q4R5F7, Q5PQN0, Q5R632, Q5R6S5
Diamond homologs: A9JTH1, B3DLU1, B3VSB7, B5FZ84, O73761, O73762, O73763, O95843, P21457, P22728, P25296, P29104, P29105, P31227, P34057, P35243, P35332, P36608, P36609, P37235, P37236, P42322, P42324, P42325, P43080, P43081, P46065, P51177, P61601, P61602, P62166, P62167, P62168, P62748, P62749, P62758, P62759, P62760, P62761, P62762
SIGNOR signaling
5 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NCS1 | “down-regulates activity” | DRD2 | binding |
| NCS1 | “down-regulates activity” | GRK2 | binding |
| IL1RAPL1 | “up-regulates activity” | NCS1 | binding |
| NCS1 | “up-regulates activity” | PI4KB | |
| IL1RAPL2 | “up-regulates activity” | NCS1 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 94 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| TNFR1-induced NF-kappa-B signaling pathway | 5 | 28.0× | 6e-04 |
| MAPK family signaling cascades | 5 | 8.6× | 9e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| canonical NF-kappaB signal transduction | 5 | 22.3× | 2e-03 |
| negative regulation of canonical NF-kappaB signal transduction | 6 | 12.6× | 3e-03 |
| positive regulation of canonical NF-kappaB signal transduction | 8 | 7.1× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1933 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:130172717:G:GT | donor_gain | 1.0000 |
| 9:130172723:CTACT:C | donor_gain | 1.0000 |
| 9:130172724:TACT:T | donor_gain | 1.0000 |
| 9:130172725:ACT:A | donor_gain | 1.0000 |
| 9:130172725:ACTGT:A | donor_loss | 1.0000 |
| 9:130172726:CT:C | donor_gain | 1.0000 |
| 9:130172726:CTG:C | donor_loss | 1.0000 |
| 9:130172727:TG:T | donor_loss | 1.0000 |
| 9:130172728:G:C | donor_loss | 1.0000 |
| 9:130172728:G:GG | donor_gain | 1.0000 |
| 9:130172729:T:G | donor_loss | 1.0000 |
| 9:130200980:GTG:G | donor_gain | 1.0000 |
| 9:130217820:T:TA | acceptor_gain | 1.0000 |
| 9:130217823:T:A | acceptor_gain | 1.0000 |
| 9:130217830:A:C | acceptor_loss | 1.0000 |
| 9:130217971:G:GC | donor_loss | 1.0000 |
| 9:130219719:TGTCA:T | acceptor_loss | 1.0000 |
| 9:130219720:GTCA:G | acceptor_loss | 1.0000 |
| 9:130219721:TCA:T | acceptor_loss | 1.0000 |
| 9:130219722:CAGG:C | acceptor_loss | 1.0000 |
| 9:130219723:A:AG | acceptor_gain | 1.0000 |
| 9:130219723:A:AT | acceptor_loss | 1.0000 |
| 9:130219723:AG:A | acceptor_gain | 1.0000 |
| 9:130219723:AGGAC:A | acceptor_gain | 1.0000 |
| 9:130219724:G:GA | acceptor_gain | 1.0000 |
| 9:130219724:GG:G | acceptor_gain | 1.0000 |
| 9:130219724:GGAC:G | acceptor_gain | 1.0000 |
| 9:130219724:GGACG:G | acceptor_gain | 1.0000 |
| 9:130219797:C:G | donor_gain | 1.0000 |
| 9:130219799:ACGGT:A | donor_gain | 1.0000 |
AlphaMissense
1267 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:130217842:T:C | F34L | 1.000 |
| 9:130217843:T:C | F34S | 1.000 |
| 9:130217844:C:A | F34L | 1.000 |
| 9:130217844:C:G | F34L | 1.000 |
| 9:130219740:T:C | F82L | 1.000 |
| 9:130219742:C:A | F82L | 1.000 |
| 9:130219742:C:G | F82L | 1.000 |
| 9:130219780:G:A | G95E | 1.000 |
| 9:130219798:T:C | L101P | 1.000 |
| 9:130222655:T:C | F105L | 1.000 |
| 9:130222657:C:A | F105L | 1.000 |
| 9:130222657:C:G | F105L | 1.000 |
| 9:130222689:T:A | I116N | 1.000 |
| 9:130222721:G:C | A127P | 1.000 |
| 9:130226419:T:C | F169L | 1.000 |
| 9:130226420:T:C | F169S | 1.000 |
| 9:130226421:C:A | F169L | 1.000 |
| 9:130226421:C:G | F169L | 1.000 |
| 9:130172710:T:C | L16P | 0.999 |
| 9:130200973:T:A | V27D | 0.999 |
| 9:130217843:T:G | F34C | 0.999 |
| 9:130217870:T:C | L43P | 0.999 |
| 9:130217884:T:C | F48L | 0.999 |
| 9:130217885:T:C | F48S | 0.999 |
| 9:130217886:C:A | F48L | 0.999 |
| 9:130217886:C:G | F48L | 0.999 |
| 9:130217905:T:C | F55L | 0.999 |
| 9:130217907:C:A | F55L | 0.999 |
| 9:130217907:C:G | F55L | 0.999 |
| 9:130217908:T:C | F56L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000091266 (9:130223771 A>C,G,T), RS1000192258 (9:130228164 A>G), RS1000327841 (9:130233938 G>A,C), RS1000352424 (9:130195791 G>A,T), RS1000497876 (9:130174287 G>A), RS1000510663 (9:130212185 G>A), RS1000557203 (9:130180386 C>A), RS1000563205 (9:130210757 A>G,T), RS1000634181 (9:130222240 C>A,T), RS1000715554 (9:130185046 A>G), RS1000741134 (9:130215863 T>C), RS1000942749 (9:130199957 G>C), RS1001017349 (9:130205332 T>A,G), RS1001116912 (9:130211256 C>G), RS1001298246 (9:130205972 T>C)
Disease associations
OMIM: gene MIM:603315 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001915_24 | Alzheimer’s disease (cognitive decline) | 7.000000e-07 |
| GCST007231_10 | Tuberculosis | 2.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (2): CHEMBL4295788 (SINGLE PROTEIN), CHEMBL4296100 (PROTEIN COMPLEX)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 2 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.90 | Kd | 1250 | nM | CHEMBL3235533 |
PubChem BioAssay actives
1 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| N-(1,3-benzothiazol-2-yl)-3,3-diphenylpropanamide | 1350731: Binding affinity to human NCS1 expressed in Escherichia coli BL21 Star (DE3) by fluorescence emission assay | kd | 1.2500 | uM |
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| Estradiol | affects cotreatment, increases expression | 2 |
| Valproic Acid | increases methylation, affects expression, decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| propylparaben | increases expression | 1 |
| bisphenol A | increases expression | 1 |
| glycidyl methacrylate | increases expression | 1 |
| lead acetate | increases expression | 1 |
| methylparaben | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| cupric chloride | increases expression | 1 |
| abrine | decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Decitabine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Benzoates | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lead | affects expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4145365 | Binding | Binding affinity to human NCS1 expressed in Escherichia coli BL21 Star (DE3) by fluorescence emission assay | Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators. — J Med Chem |
Cellosaurus cell lines
1 cell lines: 1 induced pluripotent stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D6KM | HMGUi001-A-22 | Induced pluripotent stem cell | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): tuberculosis